Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa.
AuthorsCox, H S
van Cutsem, G
AffiliationBurnet Institute, Melbourne, Australia.
MetadataShow full item record
AbstractBACKGROUND: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat to tuberculosis control in high HIV prevalence countries such as South Africa, limited data is available on the burden of drug resistant tuberculosis and any association with HIV in such settings. We conducted a community-based representative survey to assess the MDR-TB burden in Khayelitsha, an urban township in South Africa with high HIV and TB prevalence. METHODOLOGY/PRINCIPAL FINDINGS: A cross-sectional survey was conducted among adult clinic attendees suspected for pulmonary tuberculosis in two large primary care clinics, together constituting 50% of the tuberculosis burden in Khayelitsha. Drug susceptibility testing (DST) for isoniazid and rifampicin was conducted using a line probe assay on positive sputum cultures, and with culture-based DST for first and second-line drugs. Between May and November 2008, culture positive pulmonary tuberculosis was diagnosed in 271 new and 264 previously treated tuberculosis suspects (sample enriched with previously treated cases). Among those with known HIV status, 55% and 71% were HIV infected respectively. MDR-TB was diagnosed in 3.3% and 7.7% of new and previously treated cases. These figures equate to an estimated case notification rate for MDR-TB of 51/100,000/year, with new cases constituting 55% of the estimated MDR-TB burden. HIV infection was not significantly associated with rifampicin resistance in multivariate analyses. CONCLUSIONS/SIGNIFICANCE: There is an extremely high burden of MDR-TB in this setting, most likely representing ongoing transmission. These data highlight the need to diagnose drug resistance among all TB cases, and for innovative models of case detection and treatment for MDR-TB, in order to interrupt transmission and control this emerging epidemic.
- The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
- Authors: Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS
- Issue date: 2012 Jul
- Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
- Authors: Coovadia YM, Mahomed S, Pillay M, Werner L, Mlisana K
- Issue date: 2013
- Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
- Authors: Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E
- Issue date: 1999 Jan
- Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
- Authors: van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S
- Issue date: 2013 Apr
- High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.
- Authors: Fairlie L, Beylis NC, Reubenson G, Moore DP, Madhi SA
- Issue date: 2011 Jan 26